These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1833899
1. [The effect of enoximone and catecholamines on renal function after open heart surgery]. Zeplin HE. Z Kardiol; 1991; 80 Suppl 4():59-62. PubMed ID: 1833899 [No Abstract] [Full Text] [Related]
4. [Comparison of new cardiac agents using differential therapeutic criteria]. Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R. Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902 [Abstract] [Full Text] [Related]
5. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine]. Orellano L, Darwisch M, Dieterich HA, Köllner V. Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898 [Abstract] [Full Text] [Related]
6. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H. Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895 [Abstract] [Full Text] [Related]
7. Comparison of cardiovascular effects of dobutamine and enoximone in treatment of low cardiac output syndrome after valvular surgery--preliminary results. George M, Lehot JJ, Bastien O, Durand PG, Estanove S. J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):12. PubMed ID: 2535301 [No Abstract] [Full Text] [Related]
12. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency]. Richard C, Thuillez C, Annane D, Bellissant E, Teboul JL. Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832 [Abstract] [Full Text] [Related]
13. [Enoximone--clinical experiences in heart surgery]. Krüger AD, Francke A, Emmrich K. Anaesthesiol Reanim; 1996 Sep; 21(3):60-8. PubMed ID: 8766397 [Abstract] [Full Text] [Related]
14. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method. Installe E, De Coster P, Gonzalez M, Brichant C, Lessire H, Cauwe F. Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466 [Abstract] [Full Text] [Related]
15. Quantitative assessment of the effects of 'inodilators' on the myocardium in patients without primary cardiac insufficiency after coronary surgery: Part II--Enoximone. Redmann K, Lunkenheimer PP, Isringhaus H, Geiger A, Rettig G, Flameng W, Demeyre T, Engel C, Peterschmidt O. Thorac Cardiovasc Surg; 1991 Jun; 39(3):129-32. PubMed ID: 1831936 [Abstract] [Full Text] [Related]
18. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. Weber KT, Janicki JS, Jain MC. J Heart Transplant; 1986 Jun; 5(2):105-12. PubMed ID: 2956397 [Abstract] [Full Text] [Related]
19. [Enoximone, a new phosphodiesterase inhibitor: the spectrum of applications during heart surgery--a comparison with dobutamine]. Boldt J, Kling D, Schuhmann E, Scheld HH, Hempelmann G. Herz; 1988 Oct; 13(5):335-42. PubMed ID: 2972597 [Abstract] [Full Text] [Related]
20. The effect of enoximone and dobutamine on hemodynamic performance after open heart surgery. A clinical comparison. Zeplin HE, Dieterich HA, Stegmann T. J Cardiovasc Surg (Torino); 1990 Oct; 31(5):574-7. PubMed ID: 2146272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]